阿苯达唑对猪体内囊尾蚴能量代谢酶活性的影响

测定了在阿苯达唑作用下猪体内囊尾蚴磷酸烯醇式丙酮酸羧激酶(PEPCK)、丙酮酸激酶(PK)、延胡索酸还原酶(FR)、异柠檬酸脱氢酶(ICD)、苹果酸脱氢酶(ME)活性的变化。结果表明，阿苯达唑可显著改变未成熟期及成熟期猪囊尾蚴的能量代谢。提示，阿苯达唑的作用机理可能是通过干扰虫体能量代谢，阻断能量的产生导致虫体死亡的。     

奥芬达唑和阿苯达唑对猪囊尾蚴作用形态学比较观察

观察了奥芬达唑和阿苯达唑对猪体内及体外培养的不同发育阶段囊尾蚴作用的形态学效果.结果表明奥芬达唑具有显著的疗效,优于阿苯达唑,且对未成熟期猪囊尾蚴的杀灭作用优于成熟期.提示奥芬达唑可能成为抗未成熟期猪囊尾蚴及治疗脑囊虫病的有效药物.     

阿苯达唑和奥芬达唑对猪囊尾蚴延胡索酸还原酶的抑制作用

研究测定了阿苯达唑和奥芬达唑对猪囊尾蚴组织匀浆延胡索酸还原酶活性的抑制作用。结果表明两种经物均能抑制延胡索酸还原酶活性，提示苯并咪唑氨基甲酸酯药物的作用机理可能是非竞争性抑制延胡索酸还原酶复合体，从而导致虫体因能量耗竭而死亡。     

阿苯达唑和奥芬达唑对体外培养猪囊尾蚴能量代谢变化的影响

测定了在阿苯达唑和奥芬达唑作用下体外培养猪囊尾蚴磷酸烯醇式丙酮酸羧激酶（PEPCK）、丙酮酸激酶（PK）、延胡索酸还原酶（FR）、苹果酸酶（ME）活性的变化及葡萄糖（GLC）、乳酸（LAC）含量的变化。结果表明，2种药物作用均可在体外作用条件下显著改变未成熟期及成熟期猪囊尾蚴的能量代谢。提示，苯并咪唑氨基甲酸酯类药物的作用机理可能是通过干扰虫体能量代谢，阻断能量的产生，导致虫体死亡。     

阿苯达唑和奥芬达唑对猪体内囊尾蚴作用酶组织化学观察

目的　采用酶组织化学技术半定量观察阿苯达唑和奥芬达唑对猪体内囊尾蚴发育过程中乳酸脱氢酶(LDH)、琥珀酸脱氢酶(SDH)、谷氨酸脱氢酶(GDH)、三磷酸腺苷酶(ATPase)、酸性磷酸酶(ACP)、碱性磷酸酶(AKP)、6-磷酸葡萄糖酶(G6Pase)、黄嘌呤氧化酶(XOD)、脂酶(FE)活性变化的影响。方法　以用药组与不用药对照组猪体内囊尾蚴周围肌组织冰冻切片测各种酶的活性。结果　表明阿苯达唑和奥芬达唑作用后,各种酶活性均出现显著性升高,随后逐渐降低。结论　揭示药物作用后,由于虫体能量代谢障碍,导致物质分解代谢和物质转运代谢代偿性增强,随后由于代谢体系被破坏而酶活性逐渐降低。     

盐酸阿苯达唑亚砜的合成

以阿苯达唑为原料,采用一锅合成法,通过氧化、酸化反应得到目标产物盐酸阿苯达唑亚砜。以丙酮为反应溶剂,当阿苯达唑和盐酸的投料比为30 g∶13 mL,阿苯达唑和双氧水的投料比为1∶1.01(n∶n),反应时间为30 min时,制备的盐酸阿苯达唑亚砜的收率为95.78%,通过IR、1H-NMR1、3C-NMR和ESI-MS分析对其产物结构进行了确证。     

阿苯达唑对自发性兔脑炎原虫病的治疗

为了有效地治疗兔脑炎原虫病,本研究根据脑炎原虫的生物学特点和对组织损伤的特征选用阿苯达唑进行了治疗试验。将28只3～4月龄隐性感染的獭兔,随机分为对照组和治疗组进行试验。治疗组按30mg／kg剂量（首次给药量为50mg／kg）,每隔12h给药1次,连续用药10d,停药1周为1个治疗期,共治疗3个疗程。对照组按正常饲养。每1疗程之后,均采血和尿液进行ELISA检测和尿沉渣虫体检查。结果,治疗组的病兔用阿苯达唑治疗3个疗程后,ELISA检测的D值均低于标准值（〈0．044）,即抗脑炎原虫血清抗体呈阴性反应,从尿沉渣中也不能检出虫体。而对照组病免的D值则大大高于正常值．从尿沉渣中均易检出虫,并有1只对照兔出现典型的神经症状,剖检后从脑组织中检出脑炎原虫性肉芽肿。经方差分析,2组间差异非常显著（P〈0．01）。试验证明,阿苯达唑对兔脑炎原虫有良好治疗作用,用药的时机以脑炎原虫还未进入脑组织时最合适,用药的剂量一定要保持有效的杀虫浓度。     

阿苯达唑、吡喹酮驱除棘球蚴的试验报告

棘球蚴是一种人畜共患寄生虫病,中间宿主山羊感染后,可引起过敏性休克、贫血、消瘦,幼畜发育迟缓,成畜生产性能减低,甚至死亡。笔者于2004～2007年对湖南湘西保靖县普绒乡白虎坡羊场进行调查,发现在400只3～4月龄羊中其感染率达到72%,于2007年12月～2008年2月用吡喹酮、苯硫米唑、左旋米唑进行治疗试验取得了很好的疗效。     

兔豆状囊尾蚴病的诊治

２００１年２月１９日，我市养兔户杨某从本市养兔专业户黄某处购入３０～４０日龄杂交兔３８只，于２月２１日下午突然发病死亡５只，体重１kg左右，并立即将全部病死兔送本站进行病理剖检，以求诊治。２月２１日晚上和２２日又分别死亡３只和１只，３０多日龄，体重不足１kg。通过流行病学调查，结合畜主反映的临床表现、病理剖检，诊断为兔豆状囊尾蚴病。并用丙硫咪唑片及时治疗，大部分康复，共死亡９只，死亡率为２３．６９％。１病原及其生活史豆状囊尾蚴寄生于兔的脏器，主要在肝脏和网膜上，呈球形，似绿豆或黄豆样水泡，透明，其中…     

牛肉中阿苯达唑及其代谢产物残留的检测

阿苯达唑是一种广谱抗蠕虫药,但是由于用药不当等原因,其在动物可食性组织中的残留可能刺激神经系统及消化系统、触发过敏反应甚至出现肝功能异常。本试验基于5μg/kg的检验限建立牛肉中的阿苯达唑及其代谢产物的检测方法——高效液相色谱法。样品中残留的阿苯达唑及其主要代谢产物阿苯达唑砜和阿苯达唑亚砜,经乙醚提取,乙腈和己烷萃取,由高效液相色谱（配紫外检测器）测定得到阿苯达唑及其亚砜与砜的平均回收率分别为71.8%～88.6%、78.1%～85.6%和83.1%～91.9%,变异系数分别为2.8%～9.2%、0.9%～4.9%和1.4%～4.8%。     

獭兔豆状囊尾蚴病用药效果观察

在獭兔的寄生虫病中,豆状囊尾蚴病是比较普遍和严重的一种,随着我国獭兔饲养量的不断增加,豆状囊尾蚴病给养兔业造成的经济损失也日益增加。临床用药不规范,治疗效果欠佳,严重影响养兔专业户的经济效益和养兔业的发展。笔者对2006～2008年河北工程大学农学院确诊家兔豆状囊尾蚴病病例进行整理总结,现报告如下。     

Chemotherapy of porcine cysticercosis with albendazole sulphoxide

Cysticercosis is a zoonotic disease of humans produced by the larval stage of swine parasite, Taenia solium. Chemotherapy of infected pigs is a possible strategy for avoiding disease transmission and improving health programs in endemic areas of cysticercosis. In this preliminary study, seven naturally infected pigs from 6 to 12 months of age were allotted to treated (n = 4) and control groups (n = 3). The treated animals received a subcutaneous injection in their forelegs and thighs of 15 mg/kg per body weight of albendazole sulphoxide (ABZSO; Pisa, Mexico) once per day for 8 days. At the same time, the control group received a subcutaneous injection of saline solution (9% NaCl). After 12 weeks, all the animals were slaughtered and at least 200 metacestodes were isolated from the muscles and brain of each animal. Using histology and the metacestode viability criteria described in this study, treated animals had no viable cysts in their muscle (0/200), while 7 of 17 (41.1%) viable cysts were observed in those isolated from their brains. In the control group, 183/200 (91.5%) muscle metacestodes were viable and from brain, 22/29 (75.8%) metacestodes were viable. The 15 mg/kg per body weight dosage of ABZSO was 100% effective against muscular cysticercosis as shown by the lack of viable cysts and the micro-calcifications in meat from the treated pigs.     

Efficacy of albendazole for treatment of naturally acquired nematode infections in Washington cattle.

Albendazole, methyl 5-propylthio-1H-benzimidazol-2-yl carbamate, was given as a bolus (7.68 to 8.18 mg/kg of body weight) to cattle naturally infected with gastrointestinal nematodes and lungworms in a controlled trial. Over 99% of adult Ostertagia ostertagi, Trichostrongylus longispicularis, Cooperia oncophora, Nematodirus helvetianus, and Dictyocaulus viviparus were removed by the treatment. Efficacy against immature O ostertagi, early fourth-stage O ostertagi, and Oesophagostomum radiatum was 95.2%, 86.6%, and 96.7%, respectively. In a field trial, the same compound administered in a paste formulation (at approximately 7.5 mg/kg) eliminated over 99% of strongylin and Moniezia eggs from feces of treated cattle.     

Efficacy of albendazole for prevention of fascioliasis in sheep

Daily doses of albendazole administered as a premix in the feed for 35 days were effective in preventing Fasciola hepatica infections in 17 sheep in three groups: 5 mg/kg/day (6 sheep) was 100% effective; 3 mg/kg/day (5 sheep) was 98% effective; and 1 mg/kg/day (6 sheep) was 42% effective. Infective cysts were given daily for 5 days during the first week of treatment, treatment was continued an additional 28 days, and sheep were necropsied 14 weeks after final cyst inoculation. There were no visible lesions in any livers of sheep given albendazole at the rate of 5 mg/kg/day or in three of five livers of sheep dosed at the rate of 3 mg/kg/day. Sheep treated with albendazole had a mean weight gain of 2.7 kg, 4.0 kg, and 4.0 kg greater than the controls for the dosages of 1, 3, and 5 mg/kg/day, respectively. Determination of bile duct damage by measurement of serum gamma-glutamyl transpeptidase activity at 9 weeks after final cyst inoculation revealed increases of 3.0X, 1.0X, and 1.1X for the dosages of 1, 3, and 5 mg/kg/day, respectively, and 2.3X for the control, as compared with 7 weeks after final cyst inoculation.     

Efficacy of selamectin in the treatment of cheyletiellosis in pet rabbits

Cheyletiellosis is a very common parasitic skin disorder of pet rabbits typically associated with pruritus and scaling. In this study, a total 23 rabbits with cheyletiellosis were treated with a single topical application of selamectin at a dose of 12 mg kg(-1). All rabbits were examined at 3 and 5 weeks after treatment. Five weeks after selamectin application, the scaling and pruritus had resolved in all 23 rabbits, and microscopic examination of epidermal debris collected by acetate tape and flea combing was all negative for mites and eggs. No side-effects were observed in any of the rabbits. This indicates that selamectin is an effective treatment for cheyletiellosis in rabbits.     

Efficacy and safety of topical administration of selamectin for treatment of ear mite infestation in rabbits

OBJECTIVE: To evaluate the efficacy and safety of topical administration of selamectin in rabbits naturally infested with Psoroptes cuniculi. DESIGN: Randomized controlled trial. ANIMALS: 48 mixed-breed domestic rabbits with active P. cuniculi mite populations and clinical ear lesions. PROCEDURES: Rabbits were randomly allocated to 1 of 6 treatment groups. On day 0, rabbits in groups 1 and 2 were given vehicle, rabbits in groups 3 and 4 were given selamectin at a dose of 6 mg/kg (2.7 mg/lb), and rabbits in groups 5 and 6 were given selamectin at a dose of 18 mg/kg (8.2 mg/lb). On day 28, rabbits in groups 2, 4, and 6 were given a second dose of vehicle or selamectin. Otoscopic examinations were performed and ear lesion size was measured weekly for 8 weeks. Quantitative viable mite counts were performed on day 56. RESULTS: On days 7 through 56, lesion sizes for all selamectin-treated groups were significantly lower than sizes for control groups; there were no significant differences in lesion sizes among selamectin-treated groups. All rabbits in the 2 control groups had viable adult P. cuniculi mites for the duration of the study, as determined by otoscopic examination, whereas all rabbits in the 4 selamectin-treated groups were free from P. cuniculi mites on days 7 through 56. No adverse reactions associated with selamectin treatment were observed. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that topical application of selamectin at a dose of 6 or 18 mg/kg can completely eliminate mites from rabbits naturally infested with P. cuniculi.     

Efficacy of topical administration of eprinomectin for treatment of ear mite infestation in six rabbits

Six rabbits naturally infested with Psoroptes cuniculi were treated topically on the skin at the base of the neck with 0.5 mg kg(-1) of 0.5% pour-on eprinomectin for cattle, twice at 14-day intervals. Efficacy of the drug was based on the disappearance of clinical signs and the absence of live mites for a period of 6 weeks. Clinical improvement was seen within 3 days of the first application; however, complete recovery of clinical signs and elimination of mites in 5/6 rabbits did not occur until the end of the study. No adverse reactions attributable to eprinomectin treatment were observed during the observation period. Results of this trial indicated that eprinomectin was partially effective in the treatment of psoroptic mange in rabbits.